F8 and hemophilia A: The FVIII BAR Tregs were effective at inducing a more tolerogenic response by suppressing T cell and memory B cell responses; however, the BAR/CAAR CD8 T cells developed for hemophilia A were more effective at completely preventing the formation of neutralizing FVIII antibodies [195,196].